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To The Editor: Thank you for providing me with 
the opportunity to comment on the above 
viewpoint. I perfectly understand that in this 
difficult situation it is hard to face the facts 
particularly when scientists from the outside 
provide a view which is not shared by at least part 
of the Libyan medical community. So let me 
summarise how I was involved in the analysis of 
the causes of the outbreak. In June 1998, 111 
coded plasma samples were sent from El-Fateh 
Children Hospital to a private international 
laboratory, Covance, located in Geneva, 
Switzerland for HIV-1 serology; all but one plasma 
had anti HIV-1 antibodies. I was at the time head 
of the HIV reference laboratory in Geneva and 
thus received in a routine procedure samples for 
confirmation of the diagnosis including western 
blot. When I found out that most of them were 
indeed HIV-1 infected, I contacted the Libyan 
WHO representative; Dr Amer Rahil and 
suggested further investigations. It was decided 
that a group of infected children and their parents 
would come to the Geneva University Hospital for 
investigations. We proposed to set up an 
epidemiological study. Dr. Claire Anne Siegrist, 
infectious disease specialist at the Children 
Hospital in Geneva and I also proposed to help in 
the management of treatment issues and, for this 
reason, asked for a medical contact in El-Fateh 
Children Hospital. These latter propositions were 
not retained but in April 1999, a group of 37 
children came with 46 parents. They had a clinical 
check-up and anamnesis was done with the help 
of an interpreter fluent in Arabic. 
A summary of clinical finding and biological data 
are published [1].  What we found is that all 
children were infected by a HIV-1 monophyletic 
recombinant circulating form from West Africa and 
40 % of them were infected with HCV. We 
excluded vertical transmission for both HIV and 
HCV on the basis of serology in parents. Thus the 
assumption on page 2 of the viewpoint mentioning 
that HCV was acquired through vertical 
transmission is incorrect since most of the mothers 
were not infected [1]. The fact that we found 
clusters of four HCV genotypes reflect simply the 
fact that HCV is much more common in Libya than 
HIV-1, thus in the case of improper sterilisation 
procedures or reuse of contaminated needles it is 
expected to have different HCV genotypes. 
On top of that we had the vaccine booklets from 
the children, most of them were vaccinated for 
hepatitis B. What was unexpected in this context 
was that around 30 % of HBV vaccinated children 
had both markers induced by vaccination (anti 
HBs Ag) and also markers (anti HBc Ag) induced 
either by natural infection or by a vaccine 
preparation containing full inactivated virions. This 
suggests that either the children have been 
immunised with an “old” vaccine preparation or 
that they have possibly been contaminated with 
HBV at the time of vaccination like it has been 
described in other circumstances when the same 
needle is used several times.   
Concerning the origin of HIV-1 infection, it is 
invariably difficult to find the source, for example 
we have observed, 7 years ago, a monophyletic 
infection with CRF-11 in around 30 drug addicts in 
the western part of Switzerland (2 and 
unpublished). This recombinant form is known to 
originate from Africa but, as in the Libyan 
outbreak, we have been unable to identify the 
initial infection. We have a number of hypotheses 
for the initial event including travelling of a drug 
addict in Africa and sharing of needles, 
contamination of a drug addict through sexual 
contact with an African etc but once there is an 
individual with high viremia sharing needles with 
partners, the mini-epidemic will soon develop. So 
it is untrue that monophyletic infection cannot 
occur (last paragraph of the view point) since we 
observe it in drug addicts in Switzerland. Others 
have reported similar observations in Spain [2,3]. 
Epidemiologists also know that it is very difficult to 
identify the source of an infection when the initial 
event occurred several years before. 
Overall, all our observations point towards a 
nosocomial infection due to suboptimal medical 
practices. We were prevented from having a 
definite evidence since neither the WHO nor us 
were allowed to explore further the situation in 
Libya with the help of our colleagues from El-
Fateh Children Hospital. A WHO report has clearly 
mentioned that HBV, HCV, HIV infections due to 
unsafe medical practices are very frequent [4]. 
In terms of public health it would be in the best 
interest of the Libyan children to conduct a large 
study in Children’s hospitals for a systematic 
detection of HCV infection whose consequences 
will appear in several years. In Western countries 
we have more or less controlled the propagation 
of HIV-1 infection in intravenous drug users but 
still frequently observe HCV infections in this 
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population suggesting that transmissibility of HCV 
is higher than that of HIV-1. 
Finally we have transmitted written reports of our 
investigations in 1999 and 2000 to Dr. Amer Rahil 
for the Health authorities of Libya. In these reports 
we also asked to have a medical contact in Libya. 
We did not receive any answer and I was 
prevented from testifying and presenting scientific 
evidence. 
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